Precision BioSciences (DTIL)
(Delayed Data from NSDQ)
$8.84 USD
+0.23 (2.67%)
Updated Aug 16, 2024 01:25 PM ET
3-Hold of 5 3
C Value B Growth D Momentum C VGM
Cash flow Statements
Fiscal Year End for Precision BioSciences, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -61.32 | -111.64 | -30.60 | -109.01 | -92.88 |
Depreciation/Amortization & Depletion | 7.74 | 8.65 | 10.18 | 9.81 | 5.32 |
Net Change from Assets/Liabilities | -41.49 | 24.11 | 19.58 | -2.01 | -2.36 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 10.95 | 33.13 | -10.02 | 13.82 | 18.90 |
Net Cash From Operating Activities | -84.11 | -45.75 | -10.85 | -87.39 | -71.02 |
Property & Equipment | -1.85 | -3.32 | -5.05 | -5.03 | -24.67 |
Acquisition/ Disposition of Subsidiaries | 8.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | -0.32 | 0.00 | -0.75 | 0.00 | 0.00 |
Net Cash from Investing Activities | 5.83 | -3.32 | -5.80 | -5.03 | -24.67 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 5.39 | 75.18 | 68.06 | 1.33 | 136.45 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | -2.51 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 19.81 | 4.97 | 0.00 | 39.55 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | -2.62 |
Net Cash from Financing Activities | 5.39 | 94.99 | 70.52 | 1.33 | 173.37 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -72.90 | 45.91 | 53.87 | -91.09 | 77.69 |
Cash at Beginning of Period | 189.58 | 143.66 | 89.80 | 180.89 | 103.19 |
Cash at End of Period | 116.68 | 189.58 | 143.66 | 89.80 | 180.89 |
Diluted Net EPS | -15.96 | -38.14 | -15.62 | -62.76 | -66.37 |
Fiscal Year End for Precision BioSciences, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 41.34 | 8.59 | -61.32 | -45.03 | -36.95 |
Depreciation/Amortization & Depletion | 2.53 | 1.31 | 7.74 | 6.39 | 4.47 |
Net Change from Assets/Liabilities | -64.80 | -20.33 | -41.49 | -44.44 | -31.76 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | -12.92 | -8.55 | 10.95 | 7.40 | 11.64 |
Net Cash From Operating Activities | -33.85 | -18.98 | -84.11 | -75.69 | -52.60 |
Property & Equipment | -0.05 | -0.03 | -1.85 | -1.91 | -1.53 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 8.00 | 8.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | -0.32 | -0.30 | -0.25 |
Net Cash from Investing Activities | -0.05 | -0.03 | 5.83 | 5.79 | -1.78 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 40.80 | 40.10 | 5.39 | 2.56 | 2.59 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 40.80 | 40.10 | 5.39 | 2.56 | 2.59 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 6.89 | 21.09 | -72.90 | -67.35 | -51.78 |
Cash at Beginning of Period | 116.68 | 116.68 | 189.58 | 189.58 | 189.58 |
Cash at End of Period | 123.57 | 137.77 | 116.68 | 122.23 | 137.79 |
Diluted Net EPS | 4.67 | 1.70 | -3.95 | -2.10 | -3.00 |